[1]
Ravasio, R. et al. 2017. The cost of a combination Anti-Retroviral Therapy (cART) optimization pathway as maintenance therapy in HIV-1 infected patients. Farmeconomia. Health economics and therapeutic pathways. 18, 1 (Nov. 2017). DOI:https://doi.org/10.7175/fe.v18i1.1325.